Note: Ingredients listed on restricted chemical lists
EC/CAS
200-679-5/68-12-2
Name of the chemical
Dimethyl formamide; N,N-dimethylformamide (DMFa)
Concentration
=0,1-<0,3 616-001-
General Information
Revision date
2021-08-15
Product name
Oxycodone Controls
Emergency telephone
+44 1444 256500, +44 1444 256561, +44 844 892 0111, +44 845 4647, +44 8454 242424, +44 7710 - 391653
Icons in SDS
Company Information
company name
Roche Diagnostics Limited
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
The product is a kit consisting of individual ingredients. The classification of the ingredients can be obtained from section 3. Section Label elements contains the resulting labelling for the kit.
Signal word
Danger
Hazard statements
H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P272 Contaminated work clothing should not be allowed out of the workplace.
Prevention
P261 Avoid breathing mist or vapours. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection. P285 In case of inadequate ventilation wear respiratory pro- tection.
Response
P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P304 + P341 IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER or doctor/ physician. P363 Wash contaminated clothing before reuse.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
